The Smartbrain Program has been developed with a solid scientific basis, with the advice from scientists of Fundació ACE and the University of Pittsburgh.

The therapeutic efficacy of Smartbrain has been scientifically proven through several medical studies carried out by specialists in the treatment of Alzheimer’s and Parkinson’s diseases, according to the requirements of evidence-based medicine, and using the Smartbrain Program itself. The results of these studies have been published in leading specialized journals:

• Cognitive impairment caused by Alzheimer’s disease – Read article
• Cognitive impairment caused by Parkinson’s disease – Read article
• Cognitive impairment caused by long-term treatment of AIDS – Read article

Smartbrain is also effective in maintaining, and even improving, the mental abilities of people institutionalized in residential care homes. – Read article

 

Besides, the Smartbrain Program is also being used to take care of other cases of cognitive impairment, such as:

• Cognitive impairment caused by chemobrain (oncological treatment by the use of chemotherapy)
• Cognitive impairment caused by ictus
• Cognitive impairment caused by brain damage
• Cognitive impairment caused by Down syndrome
• Cognitive impairment causde by COVID19

 

For more information on the evidences of the therapeutic efficacy of the Smartbrain Program, we invite you to contact us by e-mail

And if you want to know by yourself how the program works, ask now for your free trial of Smartbrain.